Search Results

You are looking at 131 - 140 of 793 items for :

  • "screening" x
Clear All
Full access

Renee W. Pinsky and Mark A. Helvie

segmented image for computer density assessment. Dense tissue appears white. In a large study, Carney et al. 19 studied the individual and combined effects of breast density and other factors on the accuracy of screening mammography in 329,495 women from 7

Full access

Robert A. Swarm

remains less than 0.01 to 0.1 mg per person per year. Current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) “go much further” than the WHO Analgesic Ladder, he noted. The NCCN Guidelines mandate universal screening for pain in all

Full access

Rachel A. Bender Ignacio, Lilie L. Lin, Lakshmi Rajdev and Elizabeth Chiao

); cytotoxic therapies; novel tumor-targeted and virally targeted therapies in both AIDS-defining cancers (eg, KS, AIDS-defining lymphomas, and cervical cancer) and non–AIDS-defining cancers (NADCs); and other screening or topical/ablative interventions

Full access

Peter F. Coccia, Alberto S. Pappo, Lynda Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Robert Goldsby, Alexandra Gubin, Robert Hayashi, Mary S. Huang, Michael P. Link, John A. Livingston, Yousif Matloub, Frederick Millard, Kevin C. Oeffinger, Diane Puccetti, Damon Reed, Steven Robinson, Abby R. Rosenberg, Tara Sanft, Holly L. Spraker-Perlman, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Nicholas Yeager, Lisa A. Gurski and Dorothy A. Shead

along with intensive screening is essential for patients receiving chemotherapy regimens associated with irreversible organ damage and/or infertility. Anticipatory nausea and vomiting (ANV), also known as conditioned, learned, or psychological nausea

Full access

Michael H. Levy, Thomas Smith, Amy Alvarez-Perez, Anthony Back, Justin N. Baker, Susan Block, Shirley N. Codada, Shalini Dalal, Maria Dans, Jean S. Kutner, Elizabeth Kvale, Sumathi Misra, William Mitchell, Todd M. Sauer, David Spiegel, Linda Sutton, Robert M. Taylor, Jennifer Temel, Roma Tickoo, Susan G. Urba, Carin Van Zyl, Sharon M. Weinstein, Mary Anne Bergman and Jillian L. Scavone

regarding screening, assessment, and management of the palliative care needs of patients with cancer and their families/caregivers. The panel continually updates these guidelines. Notable updates from 2013 and 2014 include modifications to screening and

Full access

Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Travis Bray, Jamie A. Cannon, Gregory Cooper, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, Scott E. Regenbogen, Niloy Jewel Samadder, Moshe Shike, Gideon Steinbach, David Weinberg, Mary Dwyer and Susan Darlow

-morular variant of papillary thyroid cancer, hepatoblastoma, or multiple gastrointestinal hamartomatous polyps). Detailed strategies for screening for Lynch syndrome are provided below; see the NCCN guidelines for detail on follow-up patients meeting risk criteria

Full access

Devon C. Snow and Eric A. Klein

available for metastatic prostate cancer, treatment can be curative if it is caught early. The goal of early diagnosis and radical treatment was first suggested in 1905. 2 The introduction of prostate-specific antigen (PSA) as a screening tool in the late

Full access

Robert J. Morgan, Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Mariana Castells, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O’Malley, Richard T. Penson, Steven W. Remmenga, Paul Sabbatini, Joseph T. Santoso, Russell J. Schilder, Julian Schink, Nelson Teng, Theresa L. Werner, Miranda Hughes and Mary A. Dwyer

reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. Screening Tests for Diagnosing Ovarian Cancer Most ovarian cancer is diagnosed at an advanced stage, which

Full access

Thai H. Ho and Eric Jonasch

pathogenesis of sporadic RCC and have served as a framework for the development of targeted therapies. With diverse presentations and incomplete penetrance of RCC, establishing screening guidelines for detecting early-onset RCC may help identify persons with

Full access

Yoshio Naya and Koji Okihara

. CA Cancer J Clin 2003 ; 53 : 5 – 26 . 2 Catalona WJ Smith DS Ratliff TL . Measurement of prostate-specific antigen in serum as a screening test for prostate cancer . N Engl J Med 1991 ; 324 : 1156 – 1161 . 3 Babaian RJ